BSE Live
Apr 13, 16:01Prev. Close
351.55
Open Price
342.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 13, 16:00Prev. Close
351.55
Open Price
349.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
353.55 (348)
| Balance Sheet of FDC (in Rs. Cr.) | Mar 05 | Mar 04 | |
| 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||
| SHAREHOLDER'S FUNDS | |||
| Equity Share Capital | 19.22 | 9.65 | |
| Total Share Capital | 19.22 | 9.65 | |
| Reserves and Surplus | 217.69 | 190.41 | |
| Total Reserves and Surplus | 219.09 | 191.90 | |
| Total Shareholders Funds | 238.32 | 201.55 | |
| NON-CURRENT LIABILITIES | |||
| Long Term Borrowings | 3.26 | 3.28 | |
| Deferred Tax Liabilities [Net] | 10.52 | 9.92 | |
| Other Long Term Liabilities | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 13.79 | 13.20 | |
| CURRENT LIABILITIES | |||
| Short Term Borrowings | 0.00 | 8.72 | |
| Trade Payables | 58.35 | 38.85 | |
| Other Current Liabilities | 3.63 | 2.59 | |
| Short Term Provisions | 1.41 | 11.58 | |
| Total Current Liabilities | 63.39 | 61.74 | |
| Total Capital And Liabilities | 315.49 | 276.49 | |
| ASSETS | |||
| NON-CURRENT ASSETS | |||
| Tangible Assets | 94.07 | 78.75 | |
| Intangible Assets | 0.00 | 0.00 | |
| Capital Work-In-Progress | 14.63 | 7.36 | |
| Other Assets | 0.00 | 0.00 | |
| Fixed Assets | 108.70 | 86.11 | |
| Non-Current Investments | 63.62 | 81.94 | |
| Deferred Tax Assets [Net] | 1.03 | 2.13 | |
| Long Term Loans And Advances | 0.00 | 0.00 | |
| Other Non-Current Assets | 2.92 | 4.38 | |
| Total Non-Current Assets | 176.27 | 174.57 | |
| CURRENT ASSETS | |||
| Current Investments | 0.00 | 0.00 | |
| Inventories | 56.98 | 48.07 | |
| Trade Receivables | 47.03 | 30.23 | |
| Cash And Cash Equivalents | 11.67 | 14.90 | |
| Short Term Loans And Advances | 23.54 | 8.72 | |
| OtherCurrentAssets | 0.00 | 0.00 | |
| Total Current Assets | 139.22 | 101.92 | |
| Total Assets | 315.49 | 276.49 | |
| OTHER ADDITIONAL INFORMATION | |||
| CONTINGENT LIABILITIES, COMMITMENTS | |||
| Contingent Liabilities | 24.96 | 14.11 | |
| CIF VALUE OF IMPORTS | |||
| Raw Materials | 10.64 | 12.33 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | |
| Capital Goods | 3.92 | 5.23 | |
| EXPENDITURE IN FOREIGN EXCHANGE | |||
| Expenditure In Foreign Currency | 1.21 | 0.54 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||
| Dividend Remittance In Foreign Currency | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | |||
| FOB Value Of Goods | 80.06 | 44.11 | |
| Other Earnings | 0.01 | 1.31 | |
| BONUS DETAILS | |||
| Bonus Equity Share Capital | 12.46 | 2.89 | |
| NON-CURRENT INVESTMENTS | |||
| Non-Current Investments Quoted Market Value | 63.58 | 86.66 | |
| Non-Current Investments Unquoted Book Value | 1.85 | 1.51 | |
| CURRENT INVESTMENTS | |||
| Current Investments Quoted Market Value | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- |
10.02.2026
FDC Consolidated December 2025 Net Sales at Rs 464.71 crore, up 0.13% Y-o-Y
09.02.2026
FDC Standalone December 2025 Net Sales at Rs 457.94 crore, down 0.2% Y-o-Y
11.11.2025
FDC Standalone September 2025 Net Sales at Rs 461.74 crore, down 8.58% Y-o-Y
07.11.2025
FDC Consolidated September 2025 Net Sales at Rs 473.03 crore, down 7.94% Y-o-Y
10.02.2026
FDC Consolidated December 2025 Net Sales at Rs 464.71 crore, up 0.13% Y-o-Y
09.02.2026
FDC Standalone December 2025 Net Sales at Rs 457.94 crore, down 0.2% Y-o-Y
11.11.2025
FDC Standalone September 2025 Net Sales at Rs 461.74 crore, down 8.58% Y-o-Y
07.11.2025
FDC Consolidated September 2025 Net Sales at Rs 473.03 crore, down 7.94% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth